NCT05746858View on ClinicalTrials.gov

Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2027

Conditions
Diffuse Large B Cell LymphomaRelapsed Non-Hodgkin Lymphoma
Interventions
OTHER

no intervention (observational study)

No intervention (observational study)

Trial Locations (3)

Unknown

"Istituto Nazionale Tumori Fondazione G. Pascale IRCCS", Napoli

Fonadazione Policlinico Universitario A. Gemelli, Roma

Istituti Fisioterapici Ospitalieri -Istituto Regina Elena, Roma

All Listed Sponsors
collaborator

Istituti Fisioterapici Ospitalieri

OTHER

collaborator

Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

NETWORK

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05746858 - Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA) | Biotech Hunter | Biotech Hunter